PACB compared with BLSH: revenue, margins and what each company keeps, and the suppliers and customers both name

PACBPacific Biosciences of California, Inc.

Mkt capRevenueRevenue

BLSHBullish

Mkt capRevenueRevenue

Compare

PACBPacific Biosciences of California, Inc.

BLSHBullish

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PACB: latest quarter is a loss; flow not drawable. BLSH: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PACB 2

—Illumina Cambridgeunlistedsupplier

—Buyerunlistedcustomer

Shared 0

No shared counterparties.

Only BLSH 4

—Deloitte & Touche LLPunlistedsupplier

—BitGounlistedsupplier

—Fireblocksunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

SPV KY

unlistedsupplier

PACBPacific Biosciences of California, Inc.

2.36▼−9.60%· post 2.35

Mkt cap$728.9MRevenue$39MQ2 FY26Revenue$160MFY25

BLSHBullish

22.51▼−5.83%· post 22.56

ClosedNov 2 '26

Mkt cap$3.6BRevenue—Revenue—

Compare

ClosedNov 2 '26

PACBPacific Biosciences of California, Inc.

BLSHBullish

2.36▼−9.60%post 2.35

Price

22.51▼−5.83%post 22.56

$728.9M

Mkt cap

$3.6B

Q2 FY26$39M

Revenue

—

FY25$160M

Revenue

—

PACB2.36▼−9.60%vsBLSH22.51▼−5.83%ClosedNov 2 '26

Price

rebased to 0%

PACB, solidBLSH, dashed